Image

Analysis of Cutaneous Phosphorylated Alpha-Synuclein to Identify Patients at Risk of Progressing From Essential Tremor to Parkinson's Disease

Study checks skin markers to predict tremor progressing to Parkinson's.

Recruiting
50-85 years
All
Phase N/A

This study focuses on understanding if people with Essential Tremor (ET) might develop Parkinson's Disease (PD). ET causes uncontrollable shaking, mainly in the hands, and affects many older adults. Some with ET might develop PD, a brain disorder that leads to shaking and difficulty with movement. The study uses the Syn-One Test, a method that involves taking a small piece of skin (a skin biopsy) to check for signs of a protein called phosphorylated alpha-synuclein (P-SYN) linked to Parkinson's. This test is less invasive and costly than other methods.

  • The study is for people aged 50-85 who have ET or ET-Plus, which includes additional mild neurological symptoms.
  • Participants must be willing to undergo the Syn-One Test and other study procedures.
  • People with certain health issues, like severe heart disease or ongoing neurological disorders, cannot join.
Study details
    Essential Tremor
    Movement Disorders
    Essential Tremor
    Essential Tremor-plus

NCT07428447

CND Life Sciences

17 October 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team


Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.